Lanza, Frank <br/><br/>
The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.  [electronic resource] 

 -  The American journal of gastroenterology  Jan 2002 
 - 58-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9270 
<br/><br/><label>Standard No.: </label>10.1111/j.1572-0241.2002.05446.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Alendronate--administration & dosage<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Tolerance<br/>Female<br/>Gastric Mucosa--drug effects<br/>Gastroscopy<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoporosis--drug therapy<br/>Reference Values<br/>Safety<br/>Severity of Illness Index<br/>Stomach Diseases--chemically induced